48,830
edits
Difference between revisions of "TFE3-rearranged renal cell carcinoma"
Jump to navigation
Jump to search
TFE3-rearranged renal cell carcinoma (view source)
Revision as of 02:36, 12 February 2014
, 02:36, 12 February 2014→Molecular
(→IHC) |
|||
| Line 79: | Line 79: | ||
==Molecular== | ==Molecular== | ||
*[[Translocation]] involving TFE3, | *[[Translocation]] involving TFE3. | ||
**The most common are:<ref name=pmid24309327 >{{Cite journal | last1 = Ellis | first1 = CL. | last2 = Eble | first2 = JN. | last3 = Subhawong | first3 = AP. | last4 = Martignoni | first4 = G. | last5 = Zhong | first5 = M. | last6 = Ladanyi | first6 = M. | last7 = Epstein | first7 = JI. | last8 = Netto | first8 = GJ. | last9 = Argani | first9 = P. | title = Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. | journal = Mod Pathol | volume = | issue = | pages = | month = Dec | year = 2013 | doi = 10.1038/modpathol.2013.208 | PMID = 24309327 }}</ref> | |||
***t(X;1)(p11.2;q21) PRCC-TFE3.<ref name=Ref_WMSP285>{{Ref WMSP|285}}</ref> | |||
***t(X;17)(p11;q25) ASPSCR1-TFE3. | |||
==See also== | ==See also== | ||